Two prefilled, disposable insulin pen devices were used: InnoLet and FlexPen (Novo Nordisk ... acting insulin (insulin lispro or insulin aspart) or the combination of 70% insulin aspart protamine ...
They were eligible if their physician believed that they required insulin therapy ... injection in a cartridge [Novo Nordisk, Kalundborg, Denmark] and NovoMix 30 FlexPen® 100 IU/ml suspension ...
Novo Nordisk said it will cut the list prices in the U.S. of two of its insulin drugs, Tresiba (insulin degludec) and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026.
according to Novo Nordisk. The company says it took part in the tender process and secured places for each of its insulin products aside from Ryzodeg (insulin degludec/insulin aspart) and Xultophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback